(Updated 3:50 and 4:49 p.m.)
ProMetic Life Sciences Inc. has entered into a partnership with biotechnology company ProThera Biologics Inc. to develop and commercialize human plasma-derived inter-alpha inhibitor proteins to treat orphan diseases, which are rare diseases affecting fewer than 200,000 people.
An independent analysis of promising economic clusters for Providence to nurture has identified five stars: life sciences, food processing and packaging, social enterprise, design coupled with advanced manufacturing, and education technology.
(Updated, 9:20 p.m.)
IlluminOss Medical has appointed Manny Avila as its new president and CEO. The developer of a minimally invasive system to repair bone fractures has been looking for a chief executive since former president and CEO Dirk Kuyper left in September 2014.